36 results
8-K
AGIO
Agios Pharmaceuticals Inc
16 Dec 22
Departure of Directors or Certain Officers
4:02pm
of Certain Officers; Compensatory Arrangements of Certain Officers.
Performance-Based Cash Bonus Plan
On December 12, 2022, the Compensation … and People Committee of the Board of Directors of Agios Pharmaceuticals, Inc. (the “Company”) adopted a performance-based cash bonus plan, pursuant to which
8-K
AGIO
Agios Pharmaceuticals Inc
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
, Ms. Milanova will be eligible to receive a discretionary annual performance and retention bonus with a target of 45% of her then annual base salary … . Milanova will receive a sign-on bonus of $150,000 in connection with the commencement of her employment with the Company. Ms. Milanova
8-K
EX-10.1
wcua1 nupmcqr1v
7 Oct 22
Departure of Directors or Certain Officers
4:05pm
8-K
7ysxzxhj91dxm
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
tihjcb1qhqqz1a5gfw
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
8-K
k88 xhzs8v
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
DEFM14A
79d5emv8e9scu95
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
o826d
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFA14A
y0l0wo7t2sgmdnpng
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-2.1
1fhcxv4f2n
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
kcqz24q hw4y9fm
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
S-3ASR
EX-1.2
76i6l0zt7k jp
30 Apr 20
Automatic shelf registration
4:19pm